Olaparib, 98%, 100mg
$199.00
In stock
SKU
Q655
Olaparib /AZD-2281/Lynparza is an FDA-approved targeted therapy for cancer including ovarian, breast, and prostate cancers. In January 2018, olaparib became the first PARP inhibitor to be approved by the FDA for gBRCAm metastatic breast cancer.
THIS PRODUCT IS NOT FOR HUMAN USE
This Product Is For Research Use Only
Cat#: Q655
Name: Olaparib (AZD-2281)
CAS#: 763113-22-0
Appearance: White solid
Purity: 98%
Chemical Formula: C24H23FN4O3
Molecular Weight: 434.46
Delivery within 3-7 Days
For Bulk quantities,
Write Your Own Review